These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4150272)

  • 1. Plasma renin and angiotensin levels in human hypertension following treatment.
    Johnston CI; Anavekar N; Chua KG; Louis WJ
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():287s-90. PubMed ID: 4150272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renin, angiotensin II, catecholamines and blood pressure in healthy subjects and in patients with essential hypertension prior and following beta-blockade].
    Schuchard J; Dahlheim H; Wober W; Grill G; Lydtin H; Thurau K
    Verh Dtsch Ges Inn Med; 1974; 80():215-8. PubMed ID: 4156113
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients.
    Bragat AC; Blumenfeld J; Sealey JE
    J Hypertens; 1997 May; 15(5):459-65. PubMed ID: 9169997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic blockade in hypertension.
    Hansson L; Werkö L
    Am Heart J; 1977 Mar; 93(3):394-402. PubMed ID: 14497
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood pressure, renin, angiotension II and catecholamines in the plasma of healthy subjects and patients with essential hypertension before and after beta blockade].
    Schuchard J; Wober W; Dahlheim H; Thurau K; Lydtin H
    Adv Clin Pharmacol; 1976; 11():61-5. PubMed ID: 25570
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma renin activity in hyper- and hypothyroidism: effect of adrenergic blocking agents.
    Hauger-Klevene JH; Brown H; Zavaleta J
    J Clin Endocrinol Metab; 1972 Apr; 34(4):625-9. PubMed ID: 4401157
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of radioimmunologic determination of renin activity and the concentration of angiotensin II in the plasma of hypertensive patients].
    Serebrovskaia IuA; Ustinova SE
    Kardiologiia; 1976 Nov; 16(11):70-7. PubMed ID: 1011470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal haemodynamics and sodium excretory capacity during urapidil treatment in patients with essential hypertension.
    Lavrijssen AT; Kroon AA; Fuss-Lejeune M; Schiffers PM; de Leeuw PW
    J Hypertens; 2000 Jul; 18(7):963-9. PubMed ID: 10930195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032).
    Aberg H
    Int J Clin Pharmacol; 1974 Mar; 9(2):98-100. PubMed ID: 4151244
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: When to measure renin.
    Lancet; 1975 Apr; 1(7910):783-4. PubMed ID: 48006
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of the hormones of the renin system in hypertensive patients.
    Sealey JE
    Clin Biochem; 1981 Oct; 14(5):273-81. PubMed ID: 6120769
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Relationship between cathecholamine and renin-angiotensin system in spontaneously hypertensive rats.
    Kajiwara N; Kobayashi Y; Hashida J; Uchiyama T; Kita T
    Jpn Heart J; 1976 May; 17(3):410-1. PubMed ID: 948137
    [No Abstract]   [Full Text] [Related]  

  • 15. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
    Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renin-angiotensin and the kallikrein-kinin systems at early stages of arterial hypertension].
    Malaia LT; Lapshina LA; Starchenko TG
    Sov Med; 1985; (12):8-13. PubMed ID: 3913008
    [No Abstract]   [Full Text] [Related]  

  • 17. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta blocking agents and arterial hypertension].
    Squadrito G
    G Clin Med; 1979 May; 60(5):347-65. PubMed ID: 39861
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal and blood pressure responses to tilting in beta-blocked essential hypertension treated with felodipine or prazosin.
    Jackson B; McGrath BP; Johnston CI
    Drugs; 1987; 34 Suppl 3():87-92. PubMed ID: 2894979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine disorders in patients with essential hypertension].
    Kokot F
    Z Gesamte Inn Med; 1976 Sep; 31(18):734-7. PubMed ID: 1007334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.